NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Insulet Corporation (PODD) Stock Analysis

Insulet Corporation (PODD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

PODD

$141.90

−$0.74 (−0.52%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PODD with… →

PODD Key Statistics

As of Oct 21, 2026
Trading
Open
$141.59
Previous Close
$142.64
Day's Range
140.81–146.63
52-Week Range
126.40–354.88
Volume
1.04M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.10
Valuation
Market Cap
$9.84B
P/E Ratio
26.57
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
18.38
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.12
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.22
EPS (ttm)Profit attributable to each share over the last twelve months.
5.34
Financials (FY)
Revenue (FY)
$2.71B+30.73%
Net Income (FY)
$247.10M−40.93%
Profit marginThe share of revenue left as profit after all costs and taxes.
12.29%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
69.35M
1-Year Return
−56.87%
Dividend and dates
Earnings Date
November 4, 2026
Avg Volume
1.71M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, PODD closed at $141.90, −56.87% over 1 year.

Insulet Corporation (PODD) has a market capitalization of $9.84B.

In fiscal 2025, PODD reported revenue of $2.71B.

PODD Stock Return by Calendar Year

Insulet Corporation (PODD) 10-year return: what $10,000 became

1 year
$10,000 $4,313
−56.87%
5 years
$10,000 $4,678
−53.22%
10 years
$10,000 $35,404
+254.04%

If you had invested $10,000 in Insulet Corporation (PODD) 10 years ago, at the close on October 21, 2016, it would have been worth $35,404 at the close on October 21, 2026: +254.04% in total, +13.48% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−50.08%
2025+8.88%
2024+20.32%
2023−26.30%
2022+10.64%
2021+4.08%
2020+49.32%
2019+115.83%
2018+14.96%
2017+83.12%
2016 (partial year)−13.42%

As of October 21, 2026.

PODD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.71B$247.10M9.1%
2024$2.07B$418.30M20.2%
2023$1.70B$206.30M12.2%
2022$1.31B$4.60M0.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.71B$1.94B$473.80M$247.10M9.1%
2024$2.07B$1.45B$308.90M$418.30M20.2%
2023$1.70B$1.16B$220.10M$206.30M12.2%
2022$1.31B$805.60M$37.60M$4.60M0.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PODD Valuation vs Medical Devices Median

Median of 145 stocks
MetricPODDMedical Devices medianvs median
P/E26.5727.082% below
P/S ratio3.222.5327% above
Profit margin12.29%−14.78%27.1 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Insulet Corporation (PODD) at $9.84B. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 5,400.

Over the past 52 weeks the price has ranged from $126.40 to $354.88. PODD last closed at $141.90 on October 21, 2026. That is −$0.74 (−0.52%) against the previous close. The latest close sits 12.26% above that 52-week low.

Financial Health

In fiscal 2025, Insulet Corporation reported revenue of $2.71B. Against the prior fiscal year total of $2.07B, that is a change of +30.73%. The same year closed with net income of $247.10M. That is −40.93% against the prior fiscal year. Profit margin runs at 12.29%. That is 27.1 percentage points above the Medical Devices median of −14.78%. Trailing earnings per share are 5.34.

Across the 4 fiscal years on file, revenue moves from $1.31B in 2022 to $2.71B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 26.57 times earnings. That is 1.88% below the Medical Devices median of 27.08. On forward earnings the ratio is 18.38. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.12. Measured against sales, the shares trade at 3.22 times revenue. On price-to-sales that is 27.41% above the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

The reported beta is 1.1. Daily returns over the trailing 10 years annualize to a volatility of 42.7%. Over the trailing twelve months the total return is −56.87%. Measured over 10 years, that is +13.48% a year compounded.

Growth & Income

The record shows no dividend for PODD.

The strongest complete calendar year on file is 2019 at +115.83%; the weakest is 2023 at −26.30%. Of the 9 complete calendar years on file, 8 finished higher. So far in 2026 the total return is −50.08%.

Peer Comparison

Insulet Corporation (PODD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Insulet Corporation PODD $9.84B 26.6
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Insulet Corporation trades at a P/E of 26.6.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Visit website →